LHLabcorp

$366.64+46% 1Y

The business

How LH's business earns

Labcorp earns 8.2% on the capital it employs against an estimated 9.0% cost of capital.

8.2%

Return on invested capital · cost of capital 9.0% · 0.78 points below the estimated cost of capital

Operating margin
10%

Operating margin · Diagnostics & Research median 7.1% · 12 months to Sep 30, 2026

Cash conversion
1.47×

Cash conversion · 1.74× a year ago · operating cash flow divided by operating profit after tax

Share count, year on year
−2.5%

Share count, year on year · fewer shares than a year ago

Operating margin by fiscal year
Operating margin by fiscal year
YearOperating margin
FY202017%
FY202123%
FY202212%
FY20236.0%
FY20248.3%
FY20259.9%
Details›
Gross margin12 months to Sep 30, 2026
29%
Operating margin12 months to Sep 30, 2026
10%
Net margin12 months to Sep 30, 2026
6.9%
Free cash flow margin
8.8%
Revenue, trailing twelve months
$14.6B
Free cash flow, trailing twelve months
$1.29B
Net income, trailing twelve months
$1.00B
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
8.2%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

Labcorp (LH) Margins and Return on Capital · Ryufin